沪亚生物国际是促进和加速源于中国的新型生物医药产品在全球合作开发的领军企业。沪亚已经与中国学术界和工业界的生物医药研究机构建立了广泛的合作关系，以此来加速来自中国的候选医药产品在世界市场上的开发和增值。沪亚目前已拥有涵盖各个治疗领域最大的中国药物技术库，并成为使中国生物医药创新实现最大价值的首选合作伙伴。沪亚在美国加州的圣地亚哥和中国上海设有总部。沪亚团队的每一位成员都有丰富的相关专业经验，许多还富有亚洲商业运作的经验。沪亚团队在推进药物和医疗器械发展至通过申报美国fda，以及最后批准及商业化方面拥有丰富的实践经验。
HUYA Bioscience International is a leader in enabling and accelerating the global co-development of novel biopharmaceutical product opportunities originating in China. HUYA has established extensive collaborations with Chinese biopharmaceutical academic and commercial organizations to speed development and value creation in worldwide markets for China-sourced product candidates. With the largest Chinese compound portfolio covering all therapeutic areas, HUYA has emerged as the partner-of-choice for building and maximizing the value for biopharmaceutical innovation in China. HUYA is jointly headquartered in San Diego, CA, and Shanghai, PRC.
